Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment
source: pixabay.com

Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment

FightMND is an Australian nonprofit organization dedicated to improving the lives of motor neurone disease patients through funding research for cures. They've successfully provided millions toward research initiatives and clinical…

Continue Reading Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment
As the ACA Faces Another Court Challenge, Patient Groups Urge Quick Action
source: pixabay.com

As the ACA Faces Another Court Challenge, Patient Groups Urge Quick Action

According to a story from newsroom.heart.org, one of the most substantial domestic policy achievements of the Obama administration was the passage of the Affordable Care Act (ACA). Since its passage,…

Continue Reading As the ACA Faces Another Court Challenge, Patient Groups Urge Quick Action
Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss
source: pixabay.com

Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss

According to a story from Medical Xpress, a team of researchers from the medical school at the University of Massachusetts has revealed new information about the nature of neurodegenerative symptoms…

Continue Reading Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss
Research Team Offers Recommendations to Improve Personalized Care for Multiple Sclerosis Patients
source: pixabay.com

Research Team Offers Recommendations to Improve Personalized Care for Multiple Sclerosis Patients

A New Working Group A team of healthcare professionals from the Institute for Quality and Efficacy in Health Care, the Drug Commission of the German Medical Association, and the Charité…

Continue Reading Research Team Offers Recommendations to Improve Personalized Care for Multiple Sclerosis Patients
Three Courageous Women With Multiple Sclerosis are Fighting the Disease by Running Marathons.
source: pixabay.com

Three Courageous Women With Multiple Sclerosis are Fighting the Disease by Running Marathons.

According to recent articles in Runner’s World Magazine, having a diagnosis of multiple sclerosis has not stopped Cheryl Hile, Jennifer Lee or Melissa Ossanna. Each woman is fighting the symptoms…

Continue Reading Three Courageous Women With Multiple Sclerosis are Fighting the Disease by Running Marathons.
Study Reveals a Key Difference Between People of Color with Multiple Sclerosis and Whites
source: pixabay.com

Study Reveals a Key Difference Between People of Color with Multiple Sclerosis and Whites

According to a story from Multiple Sclerosis News Today, a recent study has revealed a never-before-seen difference in multiple sclerosis patients of different racial backgrounds. The research found that people…

Continue Reading Study Reveals a Key Difference Between People of Color with Multiple Sclerosis and Whites
This Treatment for Multiple Sclerosis Could be on its Way to Approval in the EU
source: pixabay.com

This Treatment for Multiple Sclerosis Could be on its Way to Approval in the EU

According to a story from finanznachricten.de, the drug company Novartis recently announced that the European Medicine Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive…

Continue Reading This Treatment for Multiple Sclerosis Could be on its Way to Approval in the EU
CBD-Based Treatment for Rare Childhood Epilepsies Gets Recommendation from NICE
source: pixabay.com

CBD-Based Treatment for Rare Childhood Epilepsies Gets Recommendation from NICE

According to a story from BioPortfolio, the biopharmaceutical company GW Pharmaceuticals plc recently announced that its medicine Epidyolex has earned recommendation from the UK National Institute for Health and Care…

Continue Reading CBD-Based Treatment for Rare Childhood Epilepsies Gets Recommendation from NICE

Study Shows Tysabri Reduces Risk of Cognitive Decline for Pediatric-Onset Multiple Sclerosis Patients

The Gap Tysabri is a therapy that has shown efficacy for reducing disease activity in patients diagnosed with pediatric-onset multiple sclerosis (POMS). Previous investigations have indicated that up to 58%…

Continue Reading Study Shows Tysabri Reduces Risk of Cognitive Decline for Pediatric-Onset Multiple Sclerosis Patients
“I Could Die:” Vocalist from The Script Talks About Wilson’s Disease Diagnosis
Free-Photos / Pixabay

“I Could Die:” Vocalist from The Script Talks About Wilson’s Disease Diagnosis

According to a story from irishmirror.ie, Danny O'Donoghue, the vocalist and keyboard player for the Irish rock band The Script, recently talked publicly about his struggle with Wilson's disease, a…

Continue Reading “I Could Die:” Vocalist from The Script Talks About Wilson’s Disease Diagnosis

The Open Targets Initiative Brings Scientists Closer to Identifying the Cause of Autoimmune Diseases

  Scientists believe that “it is in our DNA.” According to a recent article in EurekAlert, a five-year study formulated through Open Targets together with the Sanger Institute and their…

Continue Reading The Open Targets Initiative Brings Scientists Closer to Identifying the Cause of Autoimmune Diseases
Phase 3 Clinical Trial for Amyotrophic Lateral Sclerosis Has Completed Enrollment
source: pixabay.com

Phase 3 Clinical Trial for Amyotrophic Lateral Sclerosis Has Completed Enrollment

BrainStorm Cell Therapeutics has just announced that they have completed enrollment in their Phase 3 clinical trial for amyotrophic lateral sclerosis (ALS). Enrollment was initiated way back in October of…

Continue Reading Phase 3 Clinical Trial for Amyotrophic Lateral Sclerosis Has Completed Enrollment